Cim adds Align Technology (ALGN) to its portfolio

Align Technology (ALGN) : Cim added new position in Align Technology during the most recent quarter end. The investment management firm now holds 5,705 shares of Align Technology which is valued at $518,470 , the company said in a statement filed on Oct 17, 2016 with the SEC.Align Technology makes up approximately 0.25% of Cim’s portfolio.

Other Hedge Funds, Including , Eastern Bank added ALGN to its portfolio by purchasing 2,637 company shares during the most recent quarter which is valued at $239,651. Align Technology makes up approx 0.02% of Eastern Bank’s portfolio.Conestoga Capital Advisors reduced its stake in ALGN by selling 78,185 shares or 19.52% in the most recent quarter. The Hedge Fund company now holds 322,435 shares of ALGN which is valued at $29,367,380. Align Technology makes up approx 2.02% of Conestoga Capital Advisors’s portfolio.Dynamic Advisors Solutions reduced its stake in ALGN by selling 255 shares or 5.56% in the most recent quarter. The Hedge Fund company now holds 4,333 shares of ALGN which is valued at $394,650. Align Technology makes up approx 0.15% of Dynamic Advisors Solutions’s portfolio.Advisory Services Network boosted its stake in ALGN in the latest quarter, The investment management firm added 4,855 additional shares and now holds a total of 4,888 shares of Align Technology which is valued at $438,356. Align Technology makes up approx 0.08% of Advisory Services Network’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in ALGN by selling 21,911 shares or 76.13% in the most recent quarter. The Hedge Fund company now holds 6,870 shares of ALGN which is valued at $614,728.

Align Technology closed down -0.07 points or -0.08% at $90.88 with 6,30,850 shares getting traded on Friday. Post opening the session at $91.05, the shares hit an intraday low of $90.57 and an intraday high of $91.82 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Align Technology reported $0.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.14 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.48. The company had revenue of $269.40 million for the quarter, compared to analysts expectations of $258.76 million. The company’s revenue was up 28.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.

Many Wall Street Analysts have commented on Align Technology. Robert W. Baird Downgraded Align Technology on Oct 3, 2016 to ” Neutral”, Price Target of the shares are set at $96.Company shares were Reiterated by Stifel on Jul 28, 2016 to “Buy”, Firm has raised the Price Target to $ 95 from a previous price target of $82 .

Align Technology Inc. (Align) is a medical device company. The Company designs manufactures and markets a system of clear aligner therapy intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services for dentistry orthodontics and dental records storage. The Company operates through two segments: Clear Aligner known as the Invisalign system and Scanners and Services known as the iTero intraoral scanner and OrthoCAD services. The Company’s Clear Aligner segment provides malocclusion and orthodontic treatment. The Company’s Scanners and Services Segment offers iTero intraoral scanner which utilizes laser and optical scanning to capture the contours of the patient’s dentition gingival structures and the bite. It distributes products directly to customers including orthodontists and general practitioner dentists (GPs) as well as to restorative dentists including prosthodontists periodontists and oral surgeons.

Leave a Reply

Align Technology - Is it time to Sell?

Top Brokerage Firms are advising their investors on Align Technology. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.